Pharma Manufacturers & Providers - HARE - HealthCare Analyst Report Romania

Home PharmaPharma Manufacturers & Providers

03-04-2015
MoH & NHIH: Updated Framework Agreement

09-03-2015
MoH: Draft Governmental Decision on National Health Programs for 2015 - 2016 timeframe published

06-03-2015
MoH: Public debate regarding the HTA regulatory framework

20-02-2015
HARE ALERT: MoH intends to modify HTA related regulatory framework

19-02-2015
MoH: Specialised committees regulatory framework amended

19-01-2015
NHIH: Notice regarding the cost-volume agreements

05-01-2015
MoH: Cost-volume agreements passed into legislation

23-12-2014
Govern: NHP validity prolonged

09-12-2014
MoH: Application Norms for the 2014 FA prolonged

11-11-2014
MoH: New norms relevant to Health Insurance Houses other than the NHIH system

07-11-2014
MoH: Draft regulation for cost - volume agreements

05-11-2014
Clawback related regulatory framework amended

04-11-2014
Reimbursement list updated

27-10-2014
MoH: Appeal committees for HTA nominated

17-10-2014
MoH: Public debate regarding the proposed changes to the clawback regulation

16-10-2014
MoH: Amendment made to the reimbursement related regulatory framework

15-10-2014
Govern: Changes made to the NHP

09-10-2014
NHIH: Draft order amending reference prices for medical devices

09-10-2014
MoH: New changes to C2 list

08-10-2014
MoH: Clawback related amendments proposed

07-10-2014
MoH: Public debate regarding the HTA regulatory framework

01-10-2014
MoH: Draft order updating reimbursement prices for NHPs

01-10-2014
EFPIA: Reaction to the Public Consultation on 'Impact Assessment'

25-09-2014
Pharmacy Law: Amendments debated in the Parliament

11-09-2014
MoH: Draft order amending HTA regulatory framework

« Previous 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 Next »

Advanced Search

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company